Related Experiment Video
Updated: May 2, 2026
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
1.8K
Pathogenesis of hyperinflation in chronic obstructive pulmonary disease
Philippe Gagnon1, Jordan A Guenette2, Daniel Langer3
1Faculté de Médecine, Université Laval, Québec, QC, Canada ; Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC, Canada.
Summary
Lung hyperinflation, common in chronic obstructive pulmonary disease (COPD), worsens symptoms and limits activity. Understanding its causes and management is key for improving patient outcomes in COPD.
Area of Science:
- Pulmonology
- Respiratory Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) involves airflow limitation not fully reversible.
- Reduced lung elastic recoil and expiratory flow limitation cause lung hyperinflation in COPD patients.
- Dynamic hyperinflation occurs in mild and advanced COPD, impacting patient health.
Purpose of the Study:
- To review recent literature on the pathogenesis, assessment, and management of static and dynamic lung hyperinflation in COPD.
- To explore the influence of biological sex and obesity on hyperinflation.
- To discuss new insights into hyperinflation in mild COPD and its progression.
Main Methods:
- Literature review of recent studies on COPD hyperinflation.
- Analysis of factors influencing hyperinflation, including sex and obesity.
- Examination of hyperinflation's role in disease progression.
Main Results:
- Hyperinflation significantly contributes to dyspnea, exercise intolerance, and reduced physical activity in COPD.
- Both static and dynamic hyperinflation are clinically relevant in COPD.
- New evidence indicates hyperinflation occurs even in mild COPD.
Conclusions:
- Effective pharmacological and nonpharmacological interventions can reduce hyperinflation and delay ventilatory limitation in COPD.
- Further research is needed to fully understand hyperinflation's impact across different COPD stages and patient demographics.
- Addressing hyperinflation is crucial for managing COPD symptoms and improving quality of life.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
01:23Chronic Obstructive Pulmonary Disease I: Introduction
33
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
30
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
30
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K